Morgan Stanley Maintains Overweight on Corteva, Lowers Price Target to $60
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Vincent Andrews has maintained an Overweight rating on Corteva (NYSE:CTVA) but lowered the price target from $80 to $60.
November 10, 2023 | 1:57 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has maintained an Overweight rating on Corteva but lowered the price target from $80 to $60. This could potentially impact the stock's performance.
The Overweight rating indicates that Morgan Stanley expects Corteva to outperform the market. However, the reduction in price target from $80 to $60 suggests that they expect this outperformance to be at a lower price point. This could lead to a short-term neutral impact on the stock as the positive of the Overweight rating is balanced by the negative of the lower price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100